Digital polymerase chain reaction (dPCR) technology is an advanced version of the polymerase chain reaction (PCR) technology that enables users to amplify and directly quantify nucleic acids, such as DNA, RNA, cDNA, and methylated DNA with a high level of precision. The technique allows users to statistically analyze PCR products by converting exponential, analog signals obtained from conventional PCR technology to linear and digital signals.
Scope of the Report:
This report focuses on the dPCR in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
One of the primary drivers for this market is the rise in the focus on disease diagnosis and drug discovery and development. This increase in focus on medical research and drug discovery and development of several diseases is mainly driven by pharmaceutical and biotechnology companies as well as by research institutes. Also, it has been observed that governments of many developed and developing countries have been supporting research for new drug discovery and development. dPCR technology plays a vital role in drug discovery and development and for gene expression profiling, nucleic acid sequencing, and pharmacogenomics. Consequently, the major pharmaceutical and biotechnology companies will increase their adoption of dPCR technology due to high specificity, high accuracy, and productive results in developing new drug candidates. Such factors are expected to propel growth in ...
Table of Contents
1 Market Overview
1.1 dPCR Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.3.1 Research Laboratories and Academic Institutes
1.3.2 Pharma and Biotech Companies
1.3.3 Hospitals and Diagnostic Centers
1.3.4 Clinical Research Organizations
1.3.5 Forensic Laboratories
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
184.108.40.206 United States Market States and Outlook (2013-2023)
220.127.116.11 Canada Market States and Outlook (2013-2023)
18.104.22.168 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
22.214.171.124 Germany Market States and Outlook (2013-2023)
126.96.36.199 France Market States and Outlook (2013-2023)
188.8.131.52 UK Market States and Outlook (2013-2023)
184.108.40.206 Russia M ...